Principles and Guidelines for Sharing Biomedical Data for Secondary Use: The University of Chicago Perspective

Authors: Grossman, Robert L., Giger, Maryellen L., Johnson, Julie A., Marks, Jeremy D., Ridgway, Jessica P., Solway, Julian, Stadler, Walter M.

Subject Terms: Quantitative Biology - Other Quantitative Biology

Access URL: http://arxiv.org/abs/2302.02425

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Authors: Berg, Stephanie A. ^{a, ⁎}, La Rosa, Salvatore ^b, Zhang, Tian ^c, Pierorazio, Phillip M. ^d, Albiges, Laurence ^e, Beckermann, Kathryn E. ^f, Campbell, Matthew T. ^g, Carlo, Maria I. ^h, Coleman, Katie ⁱ, George, Daniel J. ^j, Geynisman, Daniel M. ^k, Johnson, Ritchie ^l, Jonasch, Eric ^g, Maranchie, Jodi K. ^m, McGregor, Bradley A. ^a, Shapiro, Daniel D. ⁿ, Singer, Eric A. ^o, Shuch, Brian M. ^p, Stadler, Walter M. ^q, Tannir, Nizar M. ^g, Zakharia, Yousef ^r, Vaishampayan, Ulka N. ^s, Thall, Peter F. ^t, Msaouel, Pavlos ^{g, u, v, ⁎}

Source: In Urologic Oncology: Seminars and Original Investigations March 2025 43(3):135-146

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia

Authors: Pyzer, Athalia R. ¹, Dillon, Laura W. ², Sharon, Elad ³, Karrison, Theodore G. ⁴, Zha, Yuanyuan ¹, Fulton, Noreen ¹, Gui, Gege ^{2, 5}, Andrew, Georgia ², Streicher, Howard ³, Sweet, Kendra ⁶, Yaghmour, George ⁷, Liu, Jane Jijun ⁸, Jonas, Brian A. ⁹, Schimmer, Aaron D. ¹⁰, Grant, Steven ¹¹, Zeidan, Amer M. ¹², Hildebrandt, Gerhard C. ¹³, Lowrey, Christopher H. ¹⁴, Mattison, Ryan J. ¹⁵, Palmisiano, Neil ¹⁶, Salhotra, Amandeep ¹⁷, Tzachanis, Dimitrios ¹⁸, Baer, Maria R. ¹⁹, Lin, Tara L. ²⁰, Patel, Prapti ²¹, Chen, Helen ³, Stadler, Walter M. ¹, Odenike, Olatoyosi ¹, Larson, Richard A. ¹, Gajewski, Thomas F. ²², Hourigan, Christopher S. ^{2, 5}, Stock, Wendy ¹, Liu, Hongtao ^{1, 23, ∗}

Source: In Blood Advances December 2024

Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma

Authors: Huang, Daniel, Lynch, Connor, Serra, Lucas M., Sweis, Randy F., Chang, Paul J., Stadler, Walter M., Szmulewitz, Russell Z., O’Donnell, Peter H., Sidana, Abhinav, Eggener, Scott E., Shalhav, Arieh L., Liauw, Stanley L., Pitroda, Sean P.

Source: In Clinical and Translational Radiation Oncology November 2024 49

Bladder-Preserving Trimodality Therapy With Capecitabine

Authors: Lynch, Connor, Sweis, Randy F., Modi, Parth, Agarwal, Piyush K., Szmulewitz, Russell Z., Stadler, Walter M., O'Donnell, Peter H., Liauw, Stanley L., Pitroda, Sean P.

Source: In Clinical Genitourinary Cancer April 2024 22(2):476-482

A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer

Authors: VanderWeele, David J., Kocherginsky, Masha, Munir, Sabah, Martone, Brenda, Sagar, Vinay, Morgans, Alicia, Stadler, Walter M., Abdulkadir, Sarki, Hussain, Maha

Source: In Clinical Genitourinary Cancer December 2022 20(6):575-580

Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors

Authors: Chablani, Priyanka V., Karrison, Theodore, Stadler, Walter M.

Source: In Clinical Genitourinary Cancer December 2022 20(6):510-514

A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience

Authors: Costello, Brian A., Bhavsar, Nrupen A., Zakharia, Yousef, Pal, Sumanta K., Vaishampayan, Ulka, Jim, Heather, Fishman, Mayer N., Molina, Ana M., Kyriakopoulos, Christos E., Tsao, Che-Kai, Appleman, Leonard J., Gartrell, Benjamin A., Hussain, Arif, Stadler, Walter M., Agarwal, Neeraj, Pachynski, Russell K., Hutson, Thomas E., Hammers, Hans J., Ryan, Christopher W., Mardekian, Jack, Borham, Azah, George, Daniel J., Harrison, Michael R.

Source: Clinical genitourinary cancer. 20(1):1-10

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167675040.0x000001&indx=1&recIds=ETOCvdc_100167675040.0x000001

NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma

Authors: Paintal, Ajit, Tjota, Melissa Y., Wang, Peng, Fitzpatrick, Carrie, Wanjari, Pankhuri, Stadler, Walter M., Gallan, Alexander J., Segal, Jeremy, Antic, Tatjana

Source: American journal of surgical pathology. 46(5):617-627

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155242205.0x000001&indx=1&recIds=ETOCvdc_100155242205.0x000001

Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials.

Authors: George, Suzanne, Campbell, Nancy, Hillman, Shauna L., Harlos, Elizabeth S., Stein, David W. J., Chan, Miranda Y., Chow, Selina L., Elrahi, Cassandra L., Quina, Andre C., Kokolus, Maeve C., Casagni, Michelle D., Weiss, Matthias, Anderson, Daniel M., Stadler, Walter M., Hoff, Olivia C., Rivera, Donna R., Kluetz, Paul G., Mandrekar, Sumithra J., Piantadosi, Steven

Source: Cancer (0008543X); Jan2025, Vol. 131 Issue 1, p1-11, 11p

Subject Terms: ELECTRONIC health records, ELECTRONIC structure, CLINICAL trials, THERAPEUTICS, DATABASES

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Authors: Jiang, Yu, Meyers, Travis J., Emeka, Adaeze A., Cooley, Lauren Folgosa, Cooper, Phillip R., Lancki, Nicola, Helenowski, Irene, Kachuri, Linda, Lin, Daniel W., Stanford, Janet L., Newcomb, Lisa F., Kolb, Suzanne, Finelli, Antonio, Fleshner, Neil E., Komisarenko, Maria, Eastham, James A., Ehdaie, Behfar, Benfante, Nicole, Logothetis, Christopher J., Gregg, Justin R., Perez, Cherie A., Garza, Sergio, Kim, Jeri, Marks, Leonard S., Delfin, Merdie, Barsa, Danielle, Vesprini, Danny, Klotz, Laurence H., Loblaw, Andrew, Mamedov, Alexandre, Goldenberg, S. Larry, Higano, Celestia S., Spillane, Maria, Wu, Eugenia, Carter, H. Ballentine, Pavlovich, Christian P., Mamawala, Mufaddal, Landis, Tricia, Carroll, Peter R., Chan, June M., Cooperberg, Matthew R., Cowan, Janet E., Morgan, Todd M., Siddiqui, Javed, Martin, Rabia, Klein, Eric A., Brittain, Karen, Gotwald, Paige, Barocas, Daniel A., Dallmer, Jeremiah R., Gordetsky, Jennifer B., Steele, Pam, Kundu, Shilajit D., Stockdale, Jazmine, Roobol, Monique J., Venderbos, Lionne D.F., Sanda, Martin G., Arnold, Rebecca, Patil, Dattatraya, Evans, Christopher P., Dall’Era, Marc A., Vij, Anjali, Costello, Anthony J., Chow, Ken, Corcoran, Niall M., Rais-Bahrami, Soroush, Phares, Courtney, Scherr, Douglas S., Flynn, Thomas, Karnes, R. Jeffrey, Koch, Michael, Dhondt, Courtney Rose, Nelson, Joel B., McBride, Dawn, Cookson, Michael S., Stratton, Kelly L., Farriester, Stephen, Hemken, Erin, Stadler, Walter M., Pera, Tuula, Banionyte, Deimante, Bianco, Fernando J., Jr., Lopez, Isabel H., Loeb, Stacy, Taneja, Samir S., Byrne, Nataliya, Amling, Christopher L., Martinez, Ann, Boileau, Luc, Gaylis, Franklin D., Petkewicz, Jacqueline, Kirwen, Nicholas, Helfand, Brian T., Xu, Jianfeng, Scholtens, Denise M., Catalona, William J., Witte, John S.

Source: In Human Genetics and Genomics Advances 13 January 2022 3(1)

Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial

Authors: Powles, Thomas, Atkins, Michael B., Escudier, Bernard, Motzer, Robert J., Rini, Brian I., Fong, Lawrence, Joseph, Richard W., Pal, Sumanta K., Sznol, Mario, Hainsworth, John, Stadler, Walter M., Hutson, Thomas E., Ravaud, Alain, Bracarda, Sergio, Suarez, Cristina, Choueiri, Toni K., Reeves, James, Cohn, Allen, Ding, Beiying, Leng, Ning, Hashimoto, Kenji, Huseni, Mahrukh, Schiff, Christina, McDermott, David F.

Source: In European Urology May 2021 79(5):665-673

Drug dosing in cancer patients with decreased kidney function: A practical approach

Authors: Sprangers, Ben, Sandhu, Geeta, Rosner, Mitchel H., Tesarova, Petra, Stadler, Walter M., Malyszko, Jolanta

Source: In Cancer Treatment Reviews February 2021 93

Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer

Authors: Lee, Richard T., Kwon, Nancy, Wu, Jimin, To, Connie, To, Steven, Szmulewitz, Russell, Tchekmedyian, Raffi, Holmes, Holly M., Olopade, Olufunmilayo I., Stadler, Walter M., Von Roenn, Jamie

Source: Cancer. 127(11):1827-1835

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121032841.0x000001&indx=1&recIds=ETOCvdc_100121032841.0x000001

Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case

Authors: Tjota, Melissa Y., Segal, Jeremy, Stadler, Walter M., Antic, Tatjana

Source: Pathology. 53(6):790-793

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162750660.0x000001&indx=1&recIds=ETOCvdc_100162750660.0x000001

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.

Authors: Stein, Mark N., Dumbrava, Ecaterina E., Teply, Benjamin A., Gergis, Usama S., Guiterrez, Martin E., Reshef, Ran, Subudhi, Sumit K., Jacquemont, Céline F., Senesac, Joseph H., Bayle, J. Henri, Scripture, Charity D., Chatwal, Monica S., Bilen, Mehmet A., Stadler, Walter M., Becerra, Carlos R.

Source: Nature Communications; 12/30/2024, Vol. 15 Issue 1, p1-13, 13p

Subject Terms: CHIMERIC antigen receptors, CASTRATION-resistant prostate cancer, PROSTATE-specific antigen, PANCREATIC cancer, PROSTATE cancer

KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

Authors: Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., Tesař, Vladimír, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Małyszko, Jolanta, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., Porta, Camillo

Source: In Kidney International December 2020 98(6):1407-1418

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Authors: Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., ladimír Tesař, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Porta, Camillo, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., Małyszko, Jolanta

Source: In Kidney International November 2020 98(5):1108-1119

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Authors: Rini, Brian I, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Suarez, Cristina, Bracarda, Sergio, Stadler, Walter M, Donskov, Frede, Lee, Jae Lyun, Hawkins, Robert, Ravaud, Alain, Alekseev, Boris, Staehler, Michael, Uemura, Motohide, De Giorgi, Ugo, Mellado, Begoña, Porta, Camillo, Melichar, Bohuslav, Gurney, Howard, Bedke, Jens, Choueiri, Toni K, Parnis, Francis, Khaznadar, Tarik, Thobhani, Alpa, Li, Shi, Piault-Louis, Elisabeth, Frantz, Gretchen, Huseni, Mahrukh, Schiff, Christina, Green, Marjorie C, Motzer, Robert J

Source: In The Lancet 15-21 June 2019 393(10189):2404-2415

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Authors: Kochanny, Sara E., Worden, Francis P., Adkins, Douglas R., Lim, Dean W., Bauman, Julie E., Wagner, Stephanie A., Brisson, Ryan J., Karrison, Theodore G., Stadler, Walter M., Vokes, Everett E., Seiwert, Tanguy Y.

Source: Cancer. 126(10):2146-2152

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139230129.0x000001&indx=1&recIds=ETOCvdc_100139230129.0x000001